Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients

Catheterization and Cardiovascular Interventions

Volumn 88, Issue 6, 2016, Pages 872-880

  Tröbs, Monique ^a   Achenbach, Stephan ^a   Röther, Jens ^a   Klinghammer, Lutz ^a   Schlundt, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

bioresorbable vascular scaffolds; revascularization; stents; thrombosis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BALLOON DILATATION; BARE METAL STENT; BIORESORBABLE SCAFFOLD; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; SCAFFOLD THROMBOSIS; STABLE ANGINA PECTORIS; THORAX PAIN; THROMBOSIS; VERY ELDERLY; ADVERSE EFFECTS; BIODEGRADABLE IMPLANT; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; CORONARY STENOSIS; DIAGNOSTIC IMAGING; DRUG ELUTING STENT; GERMANY; GRAFT OCCLUSION, VASCULAR; INCIDENCE; TIME FACTOR; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; AGED; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GERMANY; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 84964969254     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26569     Document Type: Article

References (30)

1. Rizik DG, Hermiller JB, Kereiakes DJ. The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence. Catheter Cardiovasc Interv 2015; 86:664–677.
2. Serruys PW, Chevalier B, Dudek D, Cequier A, Carrié D, Iniguez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L, Veldhof S, Peng L, Staehr P, Grundeken MJ, Ishibashi Y, Garcia-Garcia HM, Onuma Y. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II). Lancet 2015; 385:43–54.
3. Ellis SG, Kereiakes DJ, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stenose GW. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med 2015; 373:1905–1515.
4. Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J 2015; 36:3332–3342.
5. Lipinski MJ, Escarcega RO, Baker NC, Benn HA, Gaglia MA, Jr, Torguson R, Waksman R. Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: A systematic review and meta-analysis. JACC Cardiovasc Interv 2016; 9:12–24.
6. Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, Schunkert H, Fusaro M, Kimura T, Kastrati A. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials. Lancet 2016; 387:537–544.
7. Abizaid A, Ribamar Costa J, Jr., Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW. The ABSORB EXTEND study: Preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention 2015; 10:1396–1401.
8. Hoppmann P, Kufner S, Cassese S, Wiebe J, Schneider S, Pinieck S, Scheler L, Bernlochner I, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA. Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry. Catheter Cardiovasc Interv 2015; doi: 10.1002/ccd.26346. [Epub ahead of print]
9. Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 2015; 10:1144–1153.
10. Panoulas VF, Miyazaki T, Sato K, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A. Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds. EuroIntervention 2015; 10.
11. Latini RA, Granata F, Ielasi A, Varricchio A, Moscarella E, Tespili M, Cortese B. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry. Catheter Cardiovasc Interv 2016. doi: 10.1002/ccd.26516. [Epub ahead of print]
12. Gori T, Schulz E, Hink U, Kress M, Weiers N, Weissner M, Jabs A, Wenzel P, Capodanno D, Münzel T. Clinical, angiographic, functional, and imaging outcomes 12 months after implantation of drug-eluting bioresorbable vascular scaffolds in acute coronary syndromes. J Am Coll Cardiol Interv 2015; 8:770–777.
13. Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: The BVS-EXAMINATION Study. J Am Coll Cardiol Interv 2015; 8:189–197.
14. Cortese B, Ielasi A, Romagnoli E, Varricchio A, Cuculo A, Loi B, Pisano F, Corrado D, Sesana M, La Vecchia L, Summaria F, Tespili M, Silva Orrego P, Tognoni G, Steffenino G. Clinical comparison with short-term follow-up of bioresorbable vascular scaffold versus everolimus-eluting stent in primary percutaneous coronary interventions. Am J Cardiol 2015; 116:705–710.
15. Kraak RP, Hassell ME, Grundeken MJ, Koch KT, Henriques JP, Piek JJ, Baan J, Jr, Vis MM, Arkenbout EK, Tijssen JG, de Winter RJ, Wykrzykowska JJ. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: The AMC Single Centre Real World PCI Registry. EuroIntervention 2015; 10:1160–1168.
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115:2344–2351.
17. Mattesini A, Secco GG, Dall'Ara G, Ghione M, Rama-Merchan JC, Lupi A, Viceconte N, Lindsay AC, De Silva R, Foin N, Naganuma T, Valente S, Colombo A, Di Mario C. ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance. J Am Coll Cardiol Interv 2014; 7:741–750.
18. Wöhrle J, Naber C, Schmitz T, Schwencke C, Frey N, Butter C, Brachmann J, Ingwersen M, Drabik A, Markovic S, Mathey DG. Beyond the early stages: Insights from the ASSURE registry on bioresorbable vascular scaffolds. EuroIntervention 2015; 11:149–156.
19. Jaguszewski M, Ghadri JR, Zipponi M, Bataiosu DR, Diekmann J, Geyer V, Neumann CA, Huber MA, Hagl C, Erne P, Lüscher TF, Templin C. Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios. Clin Res Cardiol 2015; 104:124–135.
20. Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, Muller O, Allard L, Stauffer JC, Togni M, Goy JJ, Cook S. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. J Am Coll Cardiol 2015; 65:791–801.
21. Kocka V, Maly M, Tousek P, Buděšínský T, Lisa L, Prodanov P, Jarkovský J, Widimský P. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: A prospective multicentre study. Eur Heart J 2014; 35:787–794.
22. Azzalini L, L'Allier PL. Bioresorbable vascular scaffold thrombosis in an all-comer patient population: Single-center experience. J Invas Cardiol 2015; 27:85–92.
23. Sato K, Latib A, Panoulas VF, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A. Procedural feasibility and clinical outcomes in propensity-matched patients treated with bioresorbable scaffolds vs new-generation drug-eluting stents. Can J Cardiol 2015; 31:328–334.
24. Wiebe J, Gilbert F, Dörr O, Liebetrau C, Wilkens E, Bauer T, Elsässer A, Möllmann H, Hamm CW, Nef HM. Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population. Catheter Cardiovasc Interv 2015; 86:975–981.
25. Gongora CA, Shibuya M, Ramzipoor K, Lee C, Cheng Y, McGregor JC, Estrada EA, Granada JF, Kaluza GL. Vessel caging versus vascular restoration in the same artery: Long-term vascular remodeling and healing in response to overlapping metal stent and bioresorbable polymer scaffold. J Am Coll Cardiol Interv 2015; 8:631–632.
26. Yew KL. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI. Int J Cardiol 2015; 186:74–76.
27. Danzi GB, Sesana M, Arieti M, Villa G, Rutigliano S, Aprile A, Nicolino A, Moshiri S, Valenti R. Does optimal lesion preparation reduce the amount of acute recoil of the Absorb BVS? Insights from a real-world population. Catheter Cardiovasc Interv 2015; 86:984–991.
28. Gori T, Schulz E, Munzel T. Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds. J Am Coll Cardiol Interv 2014; 7:1194–1195.
29. Cuculi F, Puricel S, Jamshidi P, Valentin J, Kallinikou Z, Toggweiler S, Weissner M, Münzel T, Cook S, Gori T. Optical coherence tomography findings in bioresorbable vascular scaffolds thrombosis. Circ Cardiovasc Interv 2015; 8:e002518 doi: 10.1161/CIRCINTERVENTIONS.114.002518
30. Karanasos A, Van Mieghem N, van Ditzhuijzen N, Felix C, Daemen J, Autar A, Onuma Y, Kurata M, Diletti R, Valgimigli M, Kauer F, van Beusekom H, de Jaegere P, Zijlstra F, van Geuns RJ, Regar E. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: Single-center experience. Circ Cardiovasc Interv 2015; 8:e002369 pii. doi: 10.1161/CIRCINTERVENTIONS.114.002369